课题基金 / 基金详情

项目摘要

项目成果

VLADIMIR M KOLENKO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Prostate carcinogenesis involves transformation of zinc-accumulating normal epithelial cells to malignant cells, which do not accumulate zinc. We demonstrate that physiological levels of zinc inhibit activation of NFkappaB transcription factor, suppress expression of NF-kappaB-regulated proteins involved in angiogenesis and metastasis including VEGF, IL-8 and MMP-9 and sensitize prostate cancer cells to androgen deprivation and cytotoxic agents. Genes controlled by NF-kappaB contribute to malignant transformation, drug resistance and cancer progression to hormone-independent growth. The overall objective of the current proposal is to explore the role of zinc and zinc import and export proteins in the pathogenesis and progression of prostate malignancy and mechanisms of their regulation. We hypothesize that overexpression of zinc importers (hZIP1 and hZIP2) or reduced expression of proteins responsible for zinc export and intracellular distribution (ZnT1 through 9) has a functional impact on NF-kappaB activity, growth and viability of prostate cancer cells in vitro and in vivo. Specific Aim 1 will examine the expression and mechanisms of regulation of zinc import and export proteins in normal and transformed prostate cells. Specific Aim 2 will determine whether increased intracellular zinc accumulation via modulation of zinc import and export protein expression has a functional impact on NF-kappaB activity, growth and viability of prostate cancer cells. Specific Aim 3 will determine if overexpression of human zinc uptake transporters hZIP1 and hZIP2 inhibits prostate tumor progression in vivo. Parental prostate cancer cells or cells transfected with either hZIP1 or hZIP2 will be injected orthotopically into nude mice. The effects of dietary zinc supplementation on tumor growth will be examined. The proposed studies will help to understand the role of zinc in the pathogenesis of prostate malignancy and therefore, might have important consequences for the prevention and treatment of prostate cancer.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/cdd.2008.106
发表时间: 2008-11
期刊: CELL DEATH AND DIFFERENTIATION
影响因子: 12.4
作者: [Makhov, P., Golovine, K., Uzzo, R. G., Rothman, J., Crispen, P. L., Shaw, T., Scoll, B. J., Kolenko, V. M.]
通讯作者: Kolenko, V. M.
DOI: 10.1002/pros.20810
发表时间: 2008-09-15
期刊: PROSTATE
影响因子: 2.8
作者: [Golovine, Konstantin, Uzzo, Robert G., Makhov, Peter, Crispen, Paul L., Kunkle, David, Kolenko, Vladimir M.]
通讯作者: Kolenko, Vladimir M.
DOI: 10.1016/j.gene.2008.10.015
发表时间: 2009-02-15
期刊: GENE
影响因子: 3.5
作者: [Makhov, Peter, Golovine, Konstantin, Uzzo, Robert G., Wuestefeld, Torsten, Scoll, Benjamin J., Kolenko, Vladimir M.]
通讯作者: Kolenko, Vladimir M.
DOI: 10.1158/1078-0432.ccr-08-0455
发表时间: 2008-09-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者: [Golovine K, Makhov P, Uzzo RG, Shaw T, Kunkle D, Kolenko VM]
通讯作者: Kolenko VM
9
    The role of cholesterol homeostasis in enzalutamide resistance
    Piperlongumine: A Novel Inhibitor of Androgen Receptor Signaling
    • 批准号:
      8302819
    • 项目类别:
    • 资助金额:
      $8.93万
    • 财政年份:
      2012
    • 负责人:
      VLADIMIR M KOLENKO
    • 依托单位:
    Piperlongumine: A Novel Inhibitor of Androgen Receptor Signaling
    Therapeutics of XIAP Degradation by Zinc Chelators
    • 批准号:
      8064259
    • 项目类别:
    • 资助金额:
      $31.61万
    • 财政年份:
      2009
    • 负责人:
      VLADIMIR M KOLENKO
    • 依托单位:
    海外基金